A. Valenzuela, R. Guerra, and L. A. Videla, Antioxidant Properties of the Flavonoids Silybin and (+)-Cyanidanol-3: Comparison with Butylated Hydroxyanisole and Butylated Hydroxytoluene, Planta Medica, vol.52, issue.06, pp.438-440, 1986.
DOI : 10.1055/s-2007-969247

C. Loguercio and D. Festi, Silybin and the liver: From basic research to clinical practice, World Journal of Gastroenterology, vol.17, issue.18, pp.2288-2301, 2011.
DOI : 10.3748/wjg.v17.i18.2288

P. Ferenci, T. M. Scherzer, H. Kerschner, K. Rutter, S. Beinhardt et al., Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy, Gastroenterology, vol.135, issue.5, pp.1561-1567, 2008.
DOI : 10.1053/j.gastro.2008.07.072

A. Ahmed-belkacem, N. Ahnou, L. Barbotte, C. Wychowski, C. Pallier et al., Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase, Gastroenterology, vol.138, issue.3, pp.1112-1122, 2010.
DOI : 10.1053/j.gastro.2009.11.053

URL : https://hal.archives-ouvertes.fr/inserm-00465965

K. Flora, M. Hahn, H. Rosen, and K. Benner, Milk Thistle (Silybum marianum) for the Therapy of Liver Disease, The American Journal of Gastroenterology, vol.7, issue.2, pp.93-139, 1998.
DOI : 10.1016/0006-2952(86)90234-0

P. Ferenci, B. Dragosics, H. Dittrich, H. Frank, L. Benda et al., Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver, Journal of Hepatology, vol.9, issue.1, pp.105-113, 1989.
DOI : 10.1016/0168-8278(89)90083-4

K. Hruby, G. Csomos, M. Fuhrmann, and H. Thaler, Chemotherapy of Amanita phalloides Poisoning with Intravenous Silibinin, Human & Experimental Toxicology, vol.2, issue.2, pp.183-195, 1983.
DOI : 10.1177/096032718300200203

F. Yin, J. Liu, X. Ji, Y. Wang, J. Zidichouski et al., Silibinin: A novel inhibitor of A?? aggregation, Neurochemistry International, vol.58, issue.3, pp.58-399, 2011.
DOI : 10.1016/j.neuint.2010.12.017

N. Bhatia, J. Zhao, D. M. Wolf, and R. Agarwal, Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin, Cancer Letters, vol.147, issue.1-2, pp.77-84, 1999.
DOI : 10.1016/S0304-3835(99)00276-1

K. Ramasamy and R. Agarwal, Multitargeted therapy of cancer by silymarin, Cancer Letters, vol.269, issue.2, pp.352-362, 2008.
DOI : 10.1016/j.canlet.2008.03.053

G. Deep and R. Agarwal, Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer, Cancer and Metastasis Reviews, vol.14, issue.11, pp.447-463, 2010.
DOI : 10.1007/s10555-010-9237-0

L. Li, J. Zeng, Y. Gao, and D. He, Targeting silibinin in the antiproliferative pathway, Expert Opinion on Investigational Drugs, vol.10, issue.2, pp.243-255, 2010.
DOI : 10.1111/j.1745-7254.2007.00691.x

H. J. Wang, Y. Y. Jiang, X. F. Wei, H. Huang, S. Tashiro et al., Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells, Free Radical Research, vol.282, issue.1, pp.44-90, 2010.
DOI : 10.3109/10715769209079515

N. Ahmad, H. Gali, S. Javed, and R. Agarwal, Skin Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin Are Mediated via Impairment of Receptor Tyrosine Kinase Signaling and Perturbation in Cell Cycle Progression, Biochemical and Biophysical Research Communications, vol.247, issue.2, pp.247-294, 1998.
DOI : 10.1006/bbrc.1998.8748

F. Teillet, A. Boumendjel, J. Boutonnat, and X. Ronot, Flavonoids as RTK inhibitors and potential anticancer agents, Medicinal Research Reviews, vol.16, issue.8, pp.715-745, 2008.
DOI : 10.1002/med.20122

J. M. Pauff and R. Hille, Inhibition Studies of Bovine Xanthine Oxidase by Luteolin, Silibinin, Quercetin, and Curcumin, Journal of Natural Products, vol.72, issue.4, pp.725-731, 2009.
DOI : 10.1021/np8007123

A. Innocenti, I. Gülçin, A. Scozzafava, and C. T. Supuran, Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I???XV, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.17, pp.5050-5053, 2010.
DOI : 10.1016/j.bmcl.2010.07.038

URL : https://hal.archives-ouvertes.fr/hal-00127187

L. Skarydová, L. Zivná, G. Xiong, E. Maser, and V. , AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids, Chemico-Biological Interactions, vol.178, issue.1-3, pp.138-144, 2009.
DOI : 10.1016/j.cbi.2008.10.015

H. Zhao, G. E. Brandt, L. Galam, R. L. Matts, and B. S. Blagg, Identification and initial SAR of silybin: An Hsp90 inhibitor, Bioorganic & Medicinal Chemistry Letters, vol.21, issue.9, pp.2659-2664, 2011.
DOI : 10.1016/j.bmcl.2010.12.088

L. Trnkovà, D. Ricci, C. Grillo, G. Colotti, and F. Altieri, Green tea catechins can bind and modify ERp57, Biochim. Biophys. Acta, vol.2013, pp.2671-2682, 1830.

D. M. Ferrari and H. D. Söling, The protein disulphide-isomerase family: unravelling a string of folds, Biochemical Journal, vol.339, issue.1, pp.1-10, 1999.
DOI : 10.1042/bj3390001

R. B. Freedman, T. R. Hirst, and M. F. Tuite, Protein disulphide isomerase: building bridges in protein folding, Trends in Biochemical Sciences, vol.19, issue.8, pp.331-336, 1994.
DOI : 10.1016/0968-0004(94)90072-8

J. D. Oliver, F. J. Van-der-wal, N. J. Bulleid, and S. High, Interaction of the Thiol-Dependent Reductase ERp57 with Nascent Glycoproteins, Science, vol.275, issue.5296, pp.86-88, 1997.
DOI : 10.1126/science.275.5296.86

M. Molinari and A. Helenius, Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells, Nature, vol.402, pp.90-93, 1999.

J. A. Lindquist, O. N. Jensen, M. Mann, and G. J. Hämmerling, ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly, The EMBO Journal, vol.17, issue.8, pp.2186-2195, 1998.
DOI : 10.1093/emboj/17.8.2186

C. Turano, S. Coppari, F. Altieri, and A. Ferraro, Proteins of the PDI family: Unpredicted non-ER locations and functions, Journal of Cellular Physiology, vol.273, issue.2, pp.154-163, 2002.
DOI : 10.1002/jcp.10172

C. Turano, E. Gaucci, C. Grillo, and S. Chichiarelli, Abstract, Cellular and Molecular Biology Letters, vol.16, issue.4, pp.539-563, 2011.
DOI : 10.2478/s11658-011-0022-z

C. Grillo, C. D. Ambrosio, A. Scaloni, M. Maceroni, S. Merluzzi et al., Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors, Free Radic, Biol. Med, pp.41-1113, 2006.

C. Grillo, S. Coppari, C. Turano, and F. Altieri, The DNA-binding activity of protein disulfide isomerase ERp57 is associated with the a??? domain, Biochemical and Biophysical Research Communications, vol.295, issue.1, pp.295-67, 2002.
DOI : 10.1016/S0006-291X(02)00634-4

E. Gaucci, S. Chichiarelli, C. Grillo, E. Del-vecchio, M. Eufemi et al., The Binding of Antibiotics to ERp57/GRP58, The Journal of Antibiotics, vol.72, issue.6, pp.61-400, 2008.
DOI : 10.1038/ja.2008.56

A. P. Heuck and R. A. Wolosiuk, Di-fluoresceinthiocarbamyl-insulin: A Fluorescent Substrate for the Assay of Protein Disulfide Oxidoreductase Activity, Analytical Biochemistry, vol.248, issue.1, pp.94-101, 1997.
DOI : 10.1006/abio.1997.2123

L. Silvennoinen, J. Myllyharju, M. Ruoppolo, S. Orrù, M. Caterino et al., Identification and Characterization of Structural Domains of Human ERp57: ASSOCIATION WITH CALRETICULIN REQUIRES SEVERAL DOMAINS, Journal of Biological Chemistry, vol.279, issue.14, pp.279-13607, 2004.
DOI : 10.1074/jbc.M313054200

S. Coppari, F. Altieri, A. Ferraro, S. Chichiarelli, M. Eufemi et al., Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells, Journal of Cellular Biochemistry, vol.273, issue.2, pp.85-325, 2002.
DOI : 10.1002/jcb.10137

A. R. Karala and L. W. Ruddock, Bacitracin is not a specific inhibitor of protein disulfide isomerase, FEBS Journal, vol.254, issue.11, pp.2454-2462, 2010.
DOI : 10.1111/j.1742-4658.2010.07660.x

M. Frasconi, S. Chichiarelli, E. Gaucci, F. Mazzei, C. Grillo et al., Interaction of ERp57 with calreticulin: Analysis of complex formation and effects of vancomycin, Biophysical Chemistry, vol.160, issue.1, pp.160-206, 2012.
DOI : 10.1016/j.bpc.2011.09.003

URL : https://hal.archives-ouvertes.fr/pasteur-00960034

]. I. Nemere, M. C. Farach-carson, B. Rohe, T. M. Sterling, A. W. Norman et al., Ribozyme knockdown functionally links a 1,25(OH) 2 D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells, Proc. Natl. Acad. Sci. USA, pp.7392-7397, 2004.

W. Wu, G. Beilhartz, Y. Roy, C. L. Richard, M. Curtin et al., Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkB in differentiating NB4 leukemia cells, Exp. Cell Res, pp.316-1101, 2010.

C. Dufour and O. , Flavonoid???serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1721, issue.1-3, pp.164-173, 2005.
DOI : 10.1016/j.bbagen.2004.10.013

O. Dangles and C. Dufour, Flavonoid??? Protein Interactions, Flavonoids, Chemistry, Biochemistry and Applications, pp.443-469, 2006.
DOI : 10.1201/9781420039443.ch9

S. J. Mah, A. M. Ades, R. Mir, I. R. Siemens, J. R. Williamson et al., Association of solubilized angiotensin II receptors with phospholipase C-a in murine neuroblastoma NIE-115 cells, Mol. Pharmacol, pp.42-217, 1992.

. Crooke, Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C, Biochem. J, vol.261, pp.63-70, 1989.

E. Gaucci, F. Altieri, C. Turano, and S. Chichiarelli, The protein ERp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells, Journal of Cellular Biochemistry, vol.19, issue.90, 2013.
DOI : 10.1002/jcb.24590

C. Agarwal, A. Tyagi, M. Kaur, and R. Agarwal, Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells, Carcinogenesis, vol.28, issue.7, pp.1463-1470, 2007.
DOI : 10.1093/carcin/bgm042

G. G. Guo, K. Patel, V. Kumar, M. Shah, V. A. Fried et al., Association of the Chaperone Glucose-Regulated Protein 58 (GRP58/ER-60/ERp57) with Stat3 in Cytosol and Plasma Membrane Complexes, Journal of Interferon & Cytokine Research, vol.22, issue.5, pp.555-563, 2002.
DOI : 10.1089/10799900252982034

M. I. Ndubuisi, G. G. Guo, V. A. Fried, J. D. Etlinger, and P. B. Sehgal, Cellular Physiology of STAT3: Where's the Cytoplasmic Monomer?, Journal of Biological Chemistry, vol.274, issue.36, pp.274-25499, 1999.
DOI : 10.1074/jbc.274.36.25499

M. Eufemi, S. Coppari, F. Altieri, C. Grillo, A. Ferraro et al., ERp57 is present in STAT3???DNA complexes, Biochemical and Biophysical Research Communications, vol.323, issue.4, pp.323-1306, 2004.
DOI : 10.1016/j.bbrc.2004.09.009

S. Chichiarelli, E. Gaucci, A. Ferraro, C. Grillo, F. Altieri et al., Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line, Archives of Biochemistry and Biophysics, vol.494, issue.2, pp.494-178, 2010.
DOI : 10.1016/j.abb.2009.12.004

K. Raina, C. Agarwal, and R. Agarwal, Effect of silibinin in human colorectal cancer cells: Targeting the activation of NF-??B signaling, Molecular Carcinogenesis, vol.94, issue.3, pp.52-195, 2013.
DOI : 10.1002/mc.21843

Y. Sharma, C. Agarwal, A. K. Singh, and R. Agarwal, Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells, Molecular Carcinogenesis, vol.60, issue.29, pp.30-224, 2001.
DOI : 10.1002/mc.1032

L. Qi, R. P. Singh, Y. Lu, R. Agarwal, G. S. Harrison et al., Epidermal Growth Factor Receptor Mediates Silibinin-Induced Cytotoxicity in a Rat Glioma Cell Line, Cancer Biology & Therapy, vol.2, issue.5, pp.526-531, 2003.
DOI : 10.4161/cbt.2.5.452